Saturday, September 19, 2026
E-Paper
Apps
Archives
Kabul News
The Pulse of the Capital of Afghanistan , News for the Afghan Nation
LOG IN
SUBSCRIBE
Home
Business
Sports
Health
Technology
Shop
Videos
Fact Check
Contact
Search by keyword
Darren Incorvaia
Articles by Darren Incorvaia
Novartis secures new radioligand in $900M deal as competition strengthens - Fierce Biotech
Business
September 23, 2026
Refreshed Novo corrals 3 new early-stage obesity drugs from Kallyope - Fierce Biotech
Health
September 20, 2026
Scientists boycott American Diabetes Association as fallout of June conference fracas escalates - Fierce Biotech
Health
September 12, 2026
Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial - Fierce Biotech
Business
September 6, 2026
ArsenalBio sheds most of staff in pivot to in vivo CAR-T - Fierce Biotech
Business
September 2, 2026
Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety - Fierce Biotech
Business
August 13, 2026
‘Greg, you’ve got to bring back this platform’: How LifeMine won over Gates and Bezos for $188M series E - Fierce Biotech
Business
August 7, 2026
Amgen drops ph. 1 obesity drug, upping pressure on MariTide - Fierce Biotech
Business
August 6, 2026
FDA unveils plan for real-time review of clinical trial data, with AstraZeneca and Amgen already on board - Fierce Biotech
Business
April 29, 2026
Verge Genomics drops sole clinical candidate in return to AI drug discovery roots - Fierce Biotech
Health
December 20, 2025